Need professional-grade analysis? Visit stockanalysis.com
$17.63B
N/A
N/A
N/A
BGI Genomics Co Ltd (300676) trades on SHE in CNY. The company is classified in the Healthcare sector under the Diagnostics & Research industry. The stock currently trades at CNY39.35, down 6.64% from the previous close.
Over the past year, 300676 has traded between a low of CNY39.35 and a high of CNY59.25. The stock has lost 27.2% over this period. It is currently 33.6% below its 52-week high.
BGI Genomics Co Ltd has a market capitalization of $17.63B.
BGI Genomics Co., Ltd. engages in the provision of genomic sequencing services and proteomic services to academic institutions, pharmaceutical companies, health care providers and other organizations in China and internationally. The company offers DNA sequencing services covering whole genome sequencing, plant/animal whole genome sequencing, exome sequencing, de novo sequencing, and metagenomic sequencing; and mass spectrometry services, such as proteomic services and biologics characterization services. It also provides diagnostics and precision medicine, such as COVID-19 solutions, partnership opportunities, infectious diseases, and oncology services. The company was formerly known as Shenzhen BGI Medicine Co., Ltd. and changed its name to BGI Genomics Co., Ltd. in 2015. The company was founded in 1999 and is headquartered in Shenzhen, China. BGI Genomics Co., Ltd. operates as a subsidiary of BGI Group.